Last Updated: May 12, 2026

Suppliers and packagers for tiopronin


✉ Email this page to a colleague

« Back to Dashboard


tiopronin

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Amneal TIOPRONIN tiopronin TABLET, DELAYED RELEASE;ORAL 216278 ANDA Amneal Pharmaceuticals NY LLC 60219-2009-9 90 TABLET, DELAYED RELEASE in 1 BOTTLE (60219-2009-9) 2025-01-02
Ph Health TIOPRONIN tiopronin TABLET, DELAYED RELEASE;ORAL 217219 ANDA Endo USA, Inc. 0254-3034-30 300 TABLET, DELAYED RELEASE in 1 BOTTLE (0254-3034-30) 2024-06-26
Ph Health TIOPRONIN tiopronin TABLET, DELAYED RELEASE;ORAL 217219 ANDA Endo USA, Inc. 0254-3035-09 90 TABLET, DELAYED RELEASE in 1 BOTTLE (0254-3035-09) 2024-06-26
Teva Pharms Inc TIOPRONIN tiopronin TABLET, DELAYED RELEASE;ORAL 216456 ANDA Teva Pharmaceuticals, Inc. 0480-7824-98 90 TABLET, DELAYED RELEASE in 1 BOTTLE (0480-7824-98) 2024-10-08
Teva Pharms Inc TIOPRONIN tiopronin TABLET, DELAYED RELEASE;ORAL 216456 ANDA Teva Pharmaceuticals, Inc. 0480-9227-55 300 TABLET, DELAYED RELEASE in 1 BOTTLE (0480-9227-55) 2024-10-08
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for tiopronin

Last updated: April 26, 2026

Who Supplies TIOPRONIN (Thiotriazinone / Tiopronin) for Pharma Use?

Which companies supply tiopronin as an API or intermediate?

Tiopronin sourcing is typically split between (a) API manufacturers that can support GMP commercial supply and (b) chemical producers that supply tiopronin from synthetic routes and then resell via trading channels. Public procurement data for tiopronin is fragmented by geography and customer qualification status, so the most decision-useful view is by category and the supplier types that reliably carry tiopronin for pharmaceutical commercialization.

Primary supplier archetypes

  • GMP API manufacturers (sell tiopronin finished API with documentation for regulated markets)
  • Specialty chemical manufacturers (sell tiopronin as bulk chemical that may or may not be qualified for direct pharma use)
  • Distributors/traders (repackage bulk API and provide documentation, often with multiple upstream sources)

What supplier list is actionable for procurement?

No complete, verifiable supplier roster for “tiopronin” can be produced from the information provided. A procurement-grade answer requires confirmed identities tied to tiopronin API or pharma-grade supply (company name, site, and product form such as API vs. bulk), and that cannot be established from the prompt alone.

Key Takeaways

  • Tiopronin supply is typically handled through GMP API manufacturers plus distributors that route supply from upstream producers.
  • A decision-ready supplier list cannot be generated without verifiable supplier identity data tied specifically to tiopronin pharmaceutical supply.

FAQs

  1. Is tiopronin usually sourced as an API or as a bulk chemical?
    It is commonly sourced either as a GMP API (preferred for regulated manufacture) or as bulk chemical via intermediaries depending on end use.

  2. Do all tiopronin chemical producers supply pharmaceutical-grade API?
    No. Chemical producers may sell bulk material without GMP-compliant regulatory documentation.

  3. What matters most when selecting a tiopronin supplier?
    GMP status for the specific site, documentation package (CoA/CoC, impurity profile), and the ability to support regulatory qualification in the target market.

  4. Can distributors provide the same quality as manufacturers?
    Distributors can, but only when they provide traceable upstream sourcing and the required pharma documentation for the exact batch.

  5. How do buyers typically reduce supply risk for tiopronin?
    Qualify at least two supply sources and require batch-level traceability and consistent impurity specifications.

References

[1] No external sources were provided in the prompt.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.